Halozyme Therapeutics, Inc.
HALO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $420 | $62 | $176 | $116 |
| Short-Term Investments | $282 | $486 | $572 | $480 |
| Receivables | $346 | $316 | $305 | $308 |
| Inventory | $186 | $182 | $165 | $142 |
| Other Curr. Assets | $95 | $77 | $45 | $39 |
| Total Curr. Assets | $1,329 | $1,123 | $1,262 | $1,085 |
| Property Plant & Equip (Net) | $71 | $72 | $73 | $75 |
| Goodwill | $417 | $417 | $417 | $417 |
| Intangibles | $349 | $366 | $384 | $402 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $20 | $5 | $4 |
| Other NC Assets | $56 | $56 | $56 | $81 |
| Total NC Assets | $892 | $931 | $935 | $978 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,221 | $2,054 | $2,197 | $2,063 |
| Liabilities | – | – | – | – |
| Payables | $15 | $19 | $20 | $10 |
| Short-Term Debt | $711 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $111 | $0 | $0 | $0 |
| Total Curr. Liab. | $837 | $134 | $150 | $139 |
| LT Debt | $800 | $1,509 | $1,507 | $1,506 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $8 | $0 | $0 | $0 |
| Other NC Liab. | $72 | $78 | $56 | $55 |
| Total NC Liab. | $880 | $1,587 | $1,564 | $1,561 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,717 | $1,721 | $1,714 | $1,700 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $502 | $361 | $478 | $360 |
| AOCI | -$22 | -$28 | -$3 | $4 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $504 | $333 | $482 | $364 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,221 | $2,054 | $2,197 | $2,063 |
| Net Debt | $1,091 | $1,447 | $1,331 | $1,390 |